InvestorsHub Logo
Followers 18
Posts 943
Boards Moderated 0
Alias Born 03/23/2011

Re: Wakinyan_Pale_Raptor post# 100957

Friday, 05/09/2014 4:15:55 PM

Friday, May 09, 2014 4:15:55 PM

Post# of 130507
The underlying mechanism of MANF appears to be truly unique, breakthrough biology with the potential to alter the practice of medicine in various large, underserved medical applications worldwide," said David A. Lowe, PhD and member of the Amarantus Board of Directors. "These two papers are particularly striking, given the emerging evidence for overlap in mechanisms involved in Alzheimer's disease and Diabetes. They provide further support for our work and raise the spectrum of future clinical developments, alongside Retinitis Pigmentosa and Parkinson's disease, into which our current development activities with MANF could feed. We are currently focused on the translation of this tremendous biological opportunity into clinical development and are making steady progress in this regard. We are encouraged the worldwide research community continues to increase the value of our IP position by publishing such important work and is conducting much of the proof of concept work related to this fascinating molecule as we move towards clinical trials."